Agios Pharmaceuticals, Inc. AGIO
NASDAQ · United States · Health Technology
$32.48-0.77 (-2.32%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -1.69 | -1.65 | -2.1% | $44.75M | +69.5% | -14.3%$35.01→$30.02 |
| Q1 2026 | 2026-04-29 | -1.69 | -1.81 | +6.6% | — | — | +12.9%$24.80→$28.00 |
| Q4 2025 | 2026-02-12 | -1.85 | -1.97 | +6.1% | — | — | +0.9%$27.71→$27.96 |
| Q3 2025 | 2025-10-30 | -1.78 | -1.93 | +7.8% | — | — | +3.1%$41.96→$43.24 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.